NEW YORK (GenomeWeb) – WaferGen Biosystems today announced a partnership with Molecular Pathology Laboratory Network to develop next-generation sequencing-based clinical tests.

According to MPLN VP of Genomic Solutions Jamie Platt, the first product to be commercialized from the deal will be a solid tumor panel to complement the lab's Pathology Partners Program and support MPLN's expanding molecular oncology services menu.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.